1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
Sundlöv, Anna LU
; Gleisner, Katarina Sjögreen
LU
; Tennvall, Jan
LU
; Ljungberg, Michael
LU
; Warfvinge, Carl Fredrik
LU
; Holgersson, Kajsa
; Hallqvist, Andreas
; Bernhardt, Peter
and Svensson, Johanna
(2022)
In European Journal of Nuclear Medicine and Molecular Imaging
49(11).
p.3830-3840
- Contribution to journal › Article
- 2020
-
Mark
Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer : feasibility of automatic data extraction for dose–response studies
Stervik, Louise ; Pettersson, Niclas ; Scherman, Jonas ; Behrens, Claus F. ; Ceberg, Crister LU
; Engelholm, Silke
; Gunnarsson, Kerstin
; Hallqvist, Andreas
; Nyman, Jan
and Persson, Gitte F.
, et al.
(2020)
In Acta Oncologica
59(6).
p.628-635
- Contribution to journal › Article
- 2009
-
Mark
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: a phase II study from the Swedish Lung Cancer Study Group
- Contribution to journal › Published meeting abstract